Clinical Research

FMPM is currently looking for new patients for clinical research studies. We have many open studies. Please contact us at 727-548-6100 for information.

 

Previous Clinical Research Studies

  • 1. Study of the Efficacy and Safety of XXXX in Subjects with Opioid-induced Bowel Dysfunction
  • 2. Study With an Open-label Run-in to Assess the Efficacy and Safety of XXXX tablets 20 to 120 mg Once-daily in Subjects with moderate to Severe Chronic Low Back Pain
  • 3. Study to Evaluate Effectiveness and Safety of a XXXX for the Treatment of Osteoarthritis of the Knee with Open Label Safety Extension
  • 4. Study of XXXX in Patients with Lumbar Disc Herniation
  • 5. Study of XXXX in Patients with Lumbar Disc Herniation (Phase III)
  • 6. Trial Investigating the Efficacy and Safety of Intravenous XXXX in Subjects with Complex Regional Pain Syndrome Type I (CRPS-I)
  • 7. A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
  • 8. Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-Dose Long-Term Opioid Analgesic Therapy For Chronic Pain
  • 9. Clinical Trial of Structured Opioid Discontinuation Versus Continued Opioid Therapy in Suboptimal and Optimal Responders to High-Dose, Long-Term Opioid Analgesic Therapy for Chronic Pain as Measured by Quantitative Sensory Testing
  • 10. Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects with a Recent History of Moderate to Severe Chronic Low Back Pain Currently Treated with Opioids
  • 11. Study Comparing the Efficacy and Safety of 2 Dose-Regimens of TEV-48125 (1 Intravenous Administration, and 1 subcutaneous) Versus Placebo for the PreventionofChronic Cluster Headache (CCH)
  • 12. Study Comparing the Efficacy and Safety of 2 Dose-Regimens of TEV-48125 ( 1 Intravenous Administration, and 1 subcutaneous) Versus Placebo for the Prevention of Episodic Cluster Headache (ECH)
  • 13. Study to Explore the Long-Term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Prevention of Cluster Headache (LTSCH)